Evaluation of a Postcoital Sponge on Self-Reported Vaginal Health Parameters
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorAtlantic Health System
LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.
Over 18 (for pH subset, 18-45)
Sexually-active with biological men
Willing and able to use product
Resides in continental USA
Currently Pregnant or are trying to conceive
Unable to use device due to poor motor function
Unable to sign informed consent